23 March 2012 - 12:16pm | posted by | 0 comments

Lloydspharmacy rolls out asthma campaign to highlight how symptons can be controlled

Lloydspharmacy rolls out asthma campaign to highlight how symptons can be controlledLloydspharmacy rolls out asthma campaign to highlight how symptons can

An assertive campaign is being run by Lloydspharmacy to highlight how those living with asthma can control its symptoms.

Created by TDA, the campaign will include audience-specific display adverts, which will aim to drive people to a dedicated microsite, as well as including GP activity with waiting room posters, and direct mail and in-store materials.

Infomercials linked to ITV’s Daybreak will also begin to run from April, devised by Carat.

The campaign will encourage the audience to visit Lloydspharmacy stores or the microsite for a free asthma check-up.

Relevant allergy remedies will also be placed on special offer during the life of the campaign.

“Around 1 million children aged five to 12 and 4.3 million adults in the UK have asthma,” explained Peter Wilton, head of brand and marketing at Lloydspharmacy.

“Many of these people believe that day-to-day symptoms are an inevitable part of the condition. But with effective, well-managed treatment this doesn’t have to be the case. On a more sombre note, three people die from asthma every day in the UK, and 90 per cent of those deaths could be avoided. We have the expertise and resources to play a proactive role in helping people with asthma take control of their condition,” he added.

Don't miss out... Get your Marketing news by email

See all specialist newsletters

Be the first to comment on this article: sign in or register.

Latest Projects from the Profile Hub

New Forest National Park - Young David Attenborough discovers the Tech Creche

21/08/2014
Research conducted by the New Forest National Park...

Case Study | Building Blocks

20/08/2014
Building Blocks's Operations Director and Co-Founder, tell...

Social Media Training

18/08/2014
We love to share what we know and what we've learned about...